Revenue
2022
2023
2024
2025
Faron Pharmaceuticals Oy (FARN)
Price£0.3800Cached quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | €0 | €0 | €0 | €0 |
| Research & development | €12.7M | €11.7M | €19.5M | €20.7M |
| Operating expenses | €19.0M | €18.7M | €28.6M | €27.4M |
| Operating income | −€19.0M | −€18.7M | −€28.6M | −€27.4M |
| EBITDA | −€18.6M | −€18.4M | −€28.5M | −€27.1M |
| Net income | −€27.3M | −€25.9M | −€30.9M | −€28.7M |
| Basic EPSper basic share | -€0.24 | -€0.29 | -€0.37 | -€0.40 |
| Diluted EPSper diluted share | -€0.24 | -€0.29 | -€0.37 | -€0.40 |